본문 바로가기

Effect of urea cream on sorafenib-associated hand-foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
EUROPEAN JOURNAL OF CANCER140 · pp.19 · 2020
피인용
Web of Science 23Scopus 30
FWCI (Scopus)
0
JCR IF
JCR 2019 7.275
ISSN
0959-8049

저자

  1. Lee, Young-Sun제1저자Department of Internal medicine, Korea University College of Medicine, Seoul, South korea
  2. Jung, Young K.Department of Internal medicine, Korea University College of Medicine, Seoul, South korea
  3. Kim, Ji H.교신저자Department of Internal medicine, Korea University College of Medicine, Seoul, South korea
  4. Cho, Sung B.교신저자Department of internal medicine, Chonnam National University Medical School
  5. Kim, Do Y.Yonsei Liver Center, Severance Hospital, Seoul, Korea
  6. Kim, Moon Y.Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju Severance Christan Hospital
  7. Kim, Hyung J.Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea
  8. Seo, Yeon S.Department of Internal medicine, Korea University College of Medicine, Seoul, South korea
  9. 윤기태Department of internal medicine, Pusan National University school of Medicine, Pusan National University Yangsan Hospital
  10. 홍영미Department of internal medicine, Pusan National University school of Medicine, Pusan National University Yangsan Hospital
  11. Lee, Jeong-HoonDepartment of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine
  12. Lee, Hyun W.Department of Internal Medicine, Yonsei University College of Medicine
  13. Yim, Hyung J.Department of Internal medicine, Korea University College of Medicine, Seoul, South korea
  14. Jang, Byoung K.Department of Internal Medicine, Keimyung University School of Medicine
  15. Jang, Eun S.Department of Intetnal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi
  16. Jang, Jae Y.Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, Republic of Korea
  17. Hwang, Sang Y.Department of Internal Medicine, Dongnam Institute of Radiological & Medical Sciences

초록

Background: Hand-foot skin reaction (HFSR) is the most common adverse event during sorafenib treatment in patients with hepatocellular carcinoma (HCC). In the present study, we aimed to investigate the role of urea cream in the prevention of HFSR or amelioration of HFSR severity. Patients and methods: Patients with HCC were treated with either placebo cream or urea cream for 12 weeks concomitantly with sorafenib treatment. HFSR development, the Hand-Foot Skin Reaction and Quality of Life (HF-QoL) questionnaire score, and adverse events were assessed at 2, 4, 8 and 12 weeks. Results: Of the 288 patients, 247 patients, with 117 patients in the placebo control group and 130 patients in the urea cream group, were analysed. The urea cream group showed a trend towards a lower cumulative incidence of any-grade HFSR (log-rank, P = 0.247) and severe HFSR of grade II or higher (log-rank, P = 0.394) without statistical significance. In the incidence by time point, the incidence of severe HFSR of grade II or higher was significantly lower in the urea cream group than in the placebo control group at 2 weeks (13.8% versus 23.9%, P = 0.042). The urea cream group showed a significantly better HF-QoL questionnaire score than the placebo control group (11.8 versus 19.7, P = 0.014) at 12 weeks. Conclusions: Treatment with urea cream showed a lower incidence of severe sorafenib-induced HFSR at 2 weeks and reduced the tendency of HFSR development in HCC patients. Therefore, treatment with urea cream may be considered for prophylaxis or improvement of HFSR grade in HCC patients treated with sorafenib. (C) 2020 Elsevier Ltd. All rights reserved.

키워드

HepatocellularcarcinomaHand-foot skin reactionUrea creamOF-LIFE QUESTIONNAIREPHASE-IIITHERAPYHand–foot skin reactionHepatocellular carcinoma

식별자

Scopus EID
2-s2.0-85092173342
WoS UID
000588150600003